Mag4Health
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mag4Health - overview
Established
2021
Location
Grenoble, -, France
Primary Industry
Medical Devices & Equipment
About
Based in Grenoble, France, and founded in 2021, Mag4Health operates as a medtech company that develops brain imaging systems designed to effectively detect brain defects and improve brain care. In May 2023, Mag4Health raised EUR 5. 3 million in venture funding from new investors 33 California, Grenoble Angels, Momentum Biotech, Rhône Vallée Angels, Samba, and Simba Santé. As of May 2023, CEO Matthieu Prado is the CEO of the company.
The company provides Magnetoencephalography (MEG), which comprises 48 sensors, and 144 channels used to record the magnetic signature of the electrical currents generated by the neuronal activity in real time, enabling doctors to improve the care of patients with epilepsy or brain tumors, and subsequently improve clinical research and treatments of other neuronal disorders. Mag4Health plans to use its proceeds from May 2023 funding to accelerate the development of its product.
Current Investors
Samba, Grenoble Angels, Simba Santé
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.mag4health.com
Verticals
HealthTech, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.